Literature DB >> 8622992

Comparative interleukin (IL-2)/interferon IFN-gamma and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SICmac251 virus.

O Benveniste1, B Vaslin, R Le Grand, A Cheret, F Matheux, F Theodoro, M P Cranage, D Dormont.   

Abstract

Comparison of immune responses to infection by a pathogenic or a nonpathogenic immunodeficiency virus in macaques may provide insights into pathogenetic events leading to simian AIDS. This work is aimed at exploring cytokine expression during infection by simian immunodeficiency virus (SIV). We used semiquantitative reverse transcription-PCR to monitor interleukin (IL)-2/interferon (IFN)-gamma (Th1-like), and IL-4/IL-10 (Th2-like) expression in unmanipulated peripheral blood mononuclear cells (PBMCs), during the acute phase of infection of eight cynomolgus macaques (Macaca fascicularis) with a pathogenic primary isolate of SIVmac251 (full-length nef), and of four other cynomolgus macaques by an attenuated molecular clone of SIVmac251 (nef-truncated). All the monkeys became infected, as clearly shown by the presence of infected PBMCs and by seroconversion. Nevertheless, PBMC-associated virus loads and p27 antigenemia in monkeys infected by the attenuated virus clone remained lower than those observed in animals infected with the pathogenic SIVmac251 isolate. A rise of IL-10 mRNA expression occurred in both groups of monkeys coincident with the peak of viral replication. In monkeys infected with the pathogenic SIVmac251, IL-2, IL-4, and IFN-gamma mRNAs were either weakly detectable or undetectable. On the contrary, animals infected by the attenuated virus exhibited an overexpression of these cytokine mRNAs during the first weeks after inoculation. The lack of expression of these cytokines in monkeys infected with the pathogenic primary isolate may reflect early immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622992      PMCID: PMC39667          DOI: 10.1073/pnas.93.8.3658

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Specific and non-specific immunity and protection of macaques against SIV infection.

Authors:  R Le Grand; G Vogt; B Vaslin; P Roques; F Théodoro; A M Aubertin; D Dormont
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

Authors:  P A Bretscher; G Wei; J N Menon; H Bielefeldt-Ohmann
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

3.  Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis.

Authors:  E Maggi; P Biswas; G Del Prete; P Parronchi; D Macchia; C Simonelli; L Emmi; M De Carli; A Tiri; M Ricci
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

Review 4.  The simian immunodeficiency viruses.

Authors:  R C Desrosiers
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Human immunodeficiency virus causes mononuclear phagocyte dysfunction.

Authors:  G C Baldwin; J Fleischmann; Y Chung; Y Koyanagi; I S Chen; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Interleukin 1 beta, interleukin 6, tumor necrosis factor alpha, and interleukin 10 responses in peripheral blood mononuclear cells of cynomolgus macaques during acute infection with SIVmac251.

Authors:  O Benveniste; B Vaslin; R Le Grand; P Fouchet; V Omessa; F Theodoro; P Fretier; P Clayette; F Boussin; D Dormont
Journal:  AIDS Res Hum Retroviruses       Date:  1996-02-10       Impact factor: 2.205

7.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

8.  Population sequence analysis of a simian immunodeficiency virus (32H reisolate of SIVmac251): a virus stock used for international vaccine studies.

Authors:  N Almond; A Jenkins; A Slade; A Heath; M Cranage; P Kitchin
Journal:  AIDS Res Hum Retroviruses       Date:  1992-01       Impact factor: 2.205

9.  Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages.

Authors:  D Israël-Biet; J Cadranel; K Beldjord; J M Andrieu; A Jeffrey; P Even
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

10.  Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells.

Authors:  N E Street; J H Schumacher; T A Fong; H Bass; D F Fiorentino; J A Leverah; T R Mosmann
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

View more
  17 in total

1.  High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome.

Authors:  O Benveniste; N Dereuddre-Bosquet; P Clayette; C Leport; J L Vildé; D Dormont
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.

Authors:  P Brazille; N Dereuddre-Bosquet; C Leport; P Clayette; O Boyer; J-L Vildé; D Dormont; O Benveniste
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 3.  Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.

Authors:  Sheila M Keating; Evan S Jacobs; Philip J Norris
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

4.  The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection.

Authors:  J D Lifson; M A Nowak; S Goldstein; J L Rossio; A Kinter; G Vasquez; T A Wiltrout; C Brown; D Schneider; L Wahl; A L Lloyd; J Williams; W R Elkins; A S Fauci; V M Hirsch
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Differential innate immune responses to low or high dose oral SIV challenge in Rhesus macaques.

Authors:  Andre Durudas; Hui-Ling Chen; Melanie A Gasper; Vasudha Sundaravaradan; Jeffrey M Milush; Guido Silvestri; Welkin Johnson; Luis D Giavedoni; Donald L Sodora
Journal:  Curr HIV Res       Date:  2011-07       Impact factor: 1.581

6.  Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS.

Authors:  Christopher Kornfeld; Mickaël J-Y Ploquin; Ivona Pandrea; Abdourahmane Faye; Richard Onanga; Cristian Apetrei; Virginie Poaty-Mavoungou; Pierre Rouquet; Jérôme Estaquier; Lorenzo Mortara; Jean-François Desoutter; Cécile Butor; Roger Le Grand; Pierre Roques; François Simon; Françoise Barré-Sinoussi; Ousmane M Diop; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2005-03-10       Impact factor: 14.808

7.  Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages.

Authors:  D Blond; H Raoul; R Le Grand; D Dormont
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production.

Authors:  J A Mikovits; H A Young; P Vertino; J P Issa; P M Pitha; S Turcoski-Corrales; D D Taub; C L Petrow; S B Baylin; F W Ruscetti
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

Review 9.  Mucosal immunology of HIV infection.

Authors:  Huanbin Xu; Xiaolei Wang; Ronald S Veazey
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Polymorphism of human and primate RANTES, CX3CR1, CCR2 and CXCR4 genes with regard to HIV/SIV infection.

Authors:  Bénédicte Puissant; Michel Abbal; Antoine Blancher
Journal:  Immunogenetics       Date:  2003-07-23       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.